Document Detail

Platinum compounds and therapy related acute promyelocytic leukemia.
MedLine Citation:
PMID:  12522457     Owner:  NLM     Status:  MEDLINE    
Therapy related acute promyelocytic leukemia (ta-APL) is a rare complication of chemotherapy for other malignant tumors. We report two such cases, one of whom was exposed only to carboplatin two years before developing ta-APL and the other one was treated with cisplatin, etoposide and bleomycin five years prior to developing ta-APL.
Jacqueline Martin; Gautam Majumdar
Related Documents :
15621837 - Eosinophilic leukemic transformation in polycythemia rubra vera (prv).
12796597 - Interferon-alpha-induced focal segmental glomerulosclerosis in chronic myelogenous leuk...
10198627 - A case of chronic neutrophilic leukemia with deletion (11)(q23).
16487587 - An exclusive case of juvenile myelomonocytic leukemia in association with kikuchi's dis...
25193517 - Middle ear cholesteatoma treated with a mastoidectomy: a systematic review of the measu...
15151737 - Complete adult vulvar fusion: a case report.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The hematology journal : the official journal of the European Haematology Association / EHA     Volume:  3     ISSN:  1466-4860     ISO Abbreviation:  Hematol. J.     Publication Date:  2002  
Date Detail:
Created Date:  2003-01-10     Completed Date:  2003-09-26     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  100965523     Medline TA:  Hematol J     Country:  England    
Other Details:
Languages:  eng     Pagination:  321-3     Citation Subset:  IM    
Haematology Department, Doncaster Royal Infirmary, Thorne Road, Doncaster, DN2 5LT, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antineoplastic Agents / adverse effects,  therapeutic use
Carboplatin / adverse effects,  therapeutic use
Cisplatin / adverse effects,  therapeutic use
Leukemia, Promyelocytic, Acute / chemically induced*
Middle Aged
Neoplasms, Second Primary / chemically induced*
Platinum Compounds / adverse effects*,  therapeutic use
Reg. No./Substance:
0/Antineoplastic Agents; 0/Platinum Compounds; 15663-27-1/Cisplatin; 41575-94-4/Carboplatin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Successful rituximab treatment of an EBV-related lymphoproliferative disease arising after autologou...
Next Document:  Renal and cardiovascular considerations for the nonpharmacological and pharmacological therapies of ...